INS and type 1 diabetes mellitus: Hyperglycemia in type 1 diabetes (T1D), resulting from the autoimmune destruction of pancreatic β-cells, is controlled by direct insulin administration, but this therapy cannot accomplish exact physiological control of blood glucose concentrations and complications continue to progress [3].